Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$68.86 USD
+3.79 (5.82%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $69.50 +0.64 (0.93%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/24/2024
Time: -- |
6/2024 | $-0.27 | 0.00% |
Earnings Summary
For their last quarter, Viking Therapeutics (VKTX) reported earnings of -$0.26 per share, beating the Zacks Consensus Estimate of $-0.27 per share. This reflects a positive earnings surprise of 3.70%. Look out for VKTX's next earnings release expected on July 24, 2024. For the next earning release, we expect the company to report earnings of -$0.27 per share, reflecting a year-over-year decrease of 42.11%.
Earnings History
Price & Consensus
Zacks News for VKTX
Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights
VKTX: What are Zacks experts saying now?
Zacks Private Portfolio Services